Dow Up1.31% Nasdaq Up2.40%

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
1.82 Up 0.01(0.55%) Oct 21, 4:00PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Assets
Current Assets
Cash And Cash Equivalents9,258  33,602  54,425  23,502  
Short Term Investments48,981  29,303  22,511  31,644  
Net Receivables -   -  44   -  
Inventory -   -   -   -  
Other Current Assets1,698  765  742  1,863  
Total Current Assets 59,937   63,670   77,722   57,009  
Long Term Investments752  1,692   -   -  
Property Plant and Equipment334  210  276  375  
Goodwill -   -   -   -  
Intangible Assets -   -   -   -  
Accumulated Amortization -   -   -   -  
Other Assets314  1,007  706  156  
Deferred Long Term Asset Charges -   -   -  397  
Total Assets 61,337   66,579   78,704   57,937  
Liabilities
Current Liabilities
Accounts Payable6,367  6,712  8,040  9,451  
Short/Current Long Term Debt5,131  3,187  3,182  2,383  
Other Current Liabilities -   -  160  240  
Total Current Liabilities 11,498   9,899   11,382   12,074  
Long Term Debt8,292  6,006  6,786  7,549  
Other Liabilities -   -   -   -  
Deferred Long Term Liability Charges157   -   -   -  
Minority Interest -   -   -   -  
Negative Goodwill -   -   -   -  
Total Liabilities 19,947   15,905   18,168   19,623  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -   -  
Redeemable Preferred Stock -   -   -   -  
Preferred Stock -   -   -   -  
Common Stock33  33  33  24  
Retained Earnings(160,437)(150,623)(140,215)(129,979)
Treasury Stock -   -   -   -  
Capital Surplus201,793  201,265  200,715  168,255  
Other Stockholder Equity1  (1)3  14  
Total Stockholder Equity 41,390   50,674   60,536   38,314  
Net Tangible Assets 41,390   50,674   60,536   38,314  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.